Stocks and InvestingStocks and Investing
Mon, January 24, 2022
Sun, January 23, 2022
Sat, January 22, 2022
Fri, January 21, 2022
Thu, January 20, 2022
Wed, January 19, 2022

Lawrence Biegelsen Upgraded (TNDM) to Buy and Held Target at $160 on, Jan 19th, 2022


Published on 2024-10-27 19:20:47 - WOPRAI, Lawrence Biegelsen
  Print publication without navigation


Lawrence Biegelsen of Wells Fargo, Upgraded "Tandem Diabetes Care, Inc." (TNDM) to Buy and Held Target at $160 on, Jan 19th, 2022.

Lawrence has made no other calls on TNDM in the last 4 months.



There are 2 other peers that have a rating on TNDM. Out of the 2 peers that are also analyzing TNDM, 1 agrees with Lawrence's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $140 on, Thursday, November 4th, 2021


This is the rating of the analyst that currently disagrees with Lawrence


  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $138 on, Thursday, November 4th, 2021